Reuters logo
BRIEF-India's Alembic Pharma Sept-qtr consol PAT rises
November 7, 2017 / 7:02 AM / 17 days ago

BRIEF-India's Alembic Pharma Sept-qtr consol PAT rises

Nov 7 (Reuters) - Alembic Pharmaceuticals Ltd:

* Says U.S. formulations business continues to face price erosion on some key products; India branded business showing signs of recovery‍​‍​

* Sept quarter consol PAT 1.22 billion rupees versus 1.20 billion rupees year ago

* Sept quarter consol revenue from operations 7.89 billion rupees versus 8.79 billion rupees year ago Source text: bit.ly/2ziO5qJ Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below